Association of dynamic changes in serological markers with survival in de novo metastatic hormone-sensitive prostate cancer.

Authors

null

Soumyajit Roy

Rush University Medical Center, Chicago, IL

Soumyajit Roy , Amy Trinh Le , Daniel Eidelberg Spratt , Yilun Sun , Scott C. Morgan , Gaurav Marwaha , Amar Upadhyaya Kishan , Christopher J.D. Wallis , Fred Saad , Shawn Malone

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Hormone-Sensitive

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5069)

DOI

10.1200/JCO.2023.41.16_suppl.5069

Abstract #

5069

Poster Bd #

163

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Genitourinary Cancers Symposium

Survival outcomes in metastatic castration-resistant prostate cancer in the up-front treatment era.

Survival outcomes in metastatic castration-resistant prostate cancer in the up-front treatment era.

First Author: Shunsuke Kamijo

First Author: Elahe A. Mostaghel

First Author: Larissa Mendes

First Author: Joelle Helou